149 related articles for article (PubMed ID: 10429984)
21. [Effect of combined herbal medicine therapy on the expression of psoriasis-associated antigen-Pso p27 in patients with psoriasis vulgaris].
Song P; Lysvand H; Yan YH; Liu WL; Iversen OJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Feb; 31(1):6-9. PubMed ID: 19317047
[TBL] [Abstract][Full Text] [Related]
22. Detection of psoriasis-associated antigen pso p27 in sarcoidosis bronchoalveolar lavage fluid using monoclonal antibodies.
Jacobsen T; Lie BA; Lysvand H; Wiig M; Pettersen HB; Iversen OJ
Clin Immunol Immunopathol; 1996 Oct; 81(1):82-7. PubMed ID: 8808646
[TBL] [Abstract][Full Text] [Related]
23. Sequential therapy using cyclosporine and acitretin for treatment of total body psoriasis.
Short MW; Vaughan TK
Cutis; 2004 Sep; 74(3):185-8. PubMed ID: 15499760
[TBL] [Abstract][Full Text] [Related]
24. Cyclosporin A treatment in severe childhood psoriasis.
Pereira TM; Vieira AP; Fernandes JC; Sousa-Basto A
J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):651-6. PubMed ID: 16836490
[TBL] [Abstract][Full Text] [Related]
25. The autoantigen Pso p27: a post-translational modification of SCCA molecules.
Iversen OJ; Lysvand H; Hagen L
Autoimmunity; 2011 May; 44(3):229-34. PubMed ID: 21231892
[TBL] [Abstract][Full Text] [Related]
26. Algorithm to select optimal systemic anti-psoriatic drugs in relation with patients' Psoriasis Area and Severity Index score for plaque psoriasis.
Bae SH; Yun SJ; Lee JB; Kim SJ; Won YH; Lee SC
J Dermatol; 2016 Jun; 43(6):643-9. PubMed ID: 26598783
[TBL] [Abstract][Full Text] [Related]
27. Enhanced CCR9 expression levels in psoriatic skin are associated with poor clinical outcome to infliximab treatment.
Koga A; Kajihara I; Yamada S; Makino K; Ichihara A; Aoi J; Makino T; Fukushima S; Jinnin M; Ihn H
J Dermatol; 2016 May; 43(5):522-5. PubMed ID: 26507968
[TBL] [Abstract][Full Text] [Related]
28. Mechanistic and pharmacological assessment of murine IL-23 mediated psoriasiform dermatitis; implications for drug discovery.
Gauld SB; Gauvin D; Olson L; Leys L; Paulsboe S; Liu Z; Edelmayer RM; Wetter J; Salte K; Wang Y; Huang S; Honore P; McGaraughty S
J Dermatol Sci; 2018 Oct; 92(1):45-53. PubMed ID: 30149967
[TBL] [Abstract][Full Text] [Related]
29. Pustular Psoriasis of Pregnancy Successfully Treated With Cyclosporine.
Bangale-Daflapurkar S; Danve A
Am J Ther; 2016; 23(5):e1250-2. PubMed ID: 26360534
[TBL] [Abstract][Full Text] [Related]
30. Angiogenesis in psoriatic skin and its modifications after administration of etanercept: videocapillaroscopic, histological and immunohistochemical evaluation.
Campanati A; Goteri G; Simonetti O; Ganzetti G; Giuliodori K; Giuliano A; Sabato S; Stramazzotti D; Gulini E; Dusi D; De Blasio S; Fabris G; Offidani A
Int J Immunopathol Pharmacol; 2009; 22(2):371-7. PubMed ID: 19505391
[TBL] [Abstract][Full Text] [Related]
31. Decrease in enkephalin levels in psoriatic lesions after calcipotriol and mometasone furoate treatment.
Nissen JB; Avrach WW; Hansen ES; Stengaard-Pedersen K; Kragballe K
Dermatology; 1999; 198(1):11-7. PubMed ID: 10026395
[TBL] [Abstract][Full Text] [Related]
32. Computerized quantification of psoriasis lesions with colour calibration: preliminary results.
Iyatomi H; Oka H; Hagiwara M; Miyake A; Kimoto M; Ogawa K; Tanaka M
Clin Exp Dermatol; 2009 Oct; 34(7):830-3. PubMed ID: 19438532
[TBL] [Abstract][Full Text] [Related]
33. Ustekinumab improves psoriasis-related gene expression in noninvolved psoriatic skin without inhibition of the antimicrobial response.
Baerveldt EM; Onderdijk AJ; Kurek D; Kant M; Florencia EF; Ijpma AS; van der Spek PJ; Bastiaans J; Jansen PA; van Kilsdonk JW; Laman JD; Prens EP
Br J Dermatol; 2013 May; 168(5):990-8. PubMed ID: 23278632
[TBL] [Abstract][Full Text] [Related]
34. Participation of antigens related to the psoriasis associated antigen, pso p27, in immune complex formation in patients with ankylosing spondylitis.
Rødahl E; Asbakk K; Iversen OJ
Ann Rheum Dis; 1988 Aug; 47(8):628-33. PubMed ID: 3415362
[TBL] [Abstract][Full Text] [Related]
35. Use of cyclosporin in a patient with hepatitis C and pustular psoriasis.
Bomm L; Zimmermann CC; Souto R; Bressan A; Gripp A
An Bras Dermatol; 2011; 86(4 Suppl 1):S193-5. PubMed ID: 22068808
[TBL] [Abstract][Full Text] [Related]
36. Programmed cell death of keratinocytes in infliximab-treated plaque-type psoriasis.
Krüger-Krasagakis S; Galanopoulos VK; Giannikaki L; Stefanidou M; Tosca AD
Br J Dermatol; 2006 Mar; 154(3):460-6. PubMed ID: 16445776
[TBL] [Abstract][Full Text] [Related]
37. A randomized controlled trial of methotrexate and cyclosporine in the treatment of psoriasis.
Bigby M
Arch Dermatol; 2004 Mar; 140(3):347-8. PubMed ID: 15023778
[No Abstract] [Full Text] [Related]
38. A global approach to psoriatic patients through PASI score and Skindex-29.
Prignano F; Ruffo G; Ricceri F; Pescitelli L; Lotti T
G Ital Dermatol Venereol; 2011 Feb; 146(1):47-52. PubMed ID: 21317856
[TBL] [Abstract][Full Text] [Related]
39. Effect of PUVA, narrow-band UVB and cyclosporin on inflammatory cells of the psoriatic plaque.
Erkin G; Uğur Y; Gürer CK; Aşan E; Korkusuz P; Sahin S; Kölemen F
J Cutan Pathol; 2007 Mar; 34(3):213-9. PubMed ID: 17302604
[TBL] [Abstract][Full Text] [Related]
40. Nail psoriasis: a retrospective study on the effectiveness of systemic treatments (classical and biological therapy).
Sánchez-Regaña M; Sola-Ortigosa J; Alsina-Gibert M; Vidal-Fernández M; Umbert-Millet P
J Eur Acad Dermatol Venereol; 2011 May; 25(5):579-86. PubMed ID: 21198950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
